Team:TU Delft/6 July 2010 content
From 2010.igem.org
(→Lab work) |
|||
Line 28: | Line 28: | ||
{| style="color:black; background-color:white;" cellpadding="5" cellspacing="0" border="1" | {| style="color:black; background-color:white;" cellpadding="5" cellspacing="0" border="1" | ||
|'''#''' | |'''#''' | ||
- | |''' | + | |'''Sample''' |
- | |''' | + | |''' Enzyme 1''' |
+ | |'''Enzyme 2''' | ||
+ | |'''Buffer''' | ||
+ | |'''BSA''' | ||
|'''Needed fragment''' | |'''Needed fragment''' | ||
|- | |- | ||
|C1 | |C1 | ||
- | |1.15 μg J61100 | + | |1.15 μg J61100 |
- | | | + | |SpeI |
- | | | + | |PstI |
+ | |2 (BioLabs) | ||
+ | |✓ | ||
+ | |‘S–J61100 pSB1A2–P’ | ||
|- | |- | ||
|C2 | |C2 | ||
- | |1.68 μg J61101 | + | |1.68 μg J61101 |
- | | | + | |SpeI |
- | | | + | |PstI |
+ | |2 (BioLabs) | ||
+ | |✓ | ||
+ | |‘S–J61101 pSB1A2–P’ | ||
|- | |- | ||
|C3 | |C3 | ||
- | |1.30 μg J61107 | + | |1.30 μg J61107 |
- | | | + | |SpeI |
- | | | + | |PstI |
+ | |2 (BioLabs) | ||
+ | |✓ | ||
+ | |‘S–J61107 pSB1A2–P’ | ||
|- | |- | ||
|C4 | |C4 | ||
- | |0.95 μg J61117 | + | |0.95 μg J61117 |
- | | | + | |SpeI |
- | | | + | |PstI |
+ | |2 (BioLabs) | ||
+ | |✓ | ||
+ | |‘S–J61117 pSB1A2–P’ | ||
|- | |- | ||
|C5 | |C5 | ||
- | |0.51 μg J61127 | + | |0.51 μg J61127 |
- | | | + | |SpeI |
- | | | + | |PstI |
+ | |2 (BioLabs) | ||
+ | |✓ | ||
+ | |‘S–J61127 pSB1A2–P’ | ||
|- | |- | ||
|D1 | |D1 | ||
- | |2.59 μg I13401 | + | |2.59 μg I13401 |
- | | | + | |XbaI |
- | | | + | |PstI |
+ | |2 (BioLabs) | ||
+ | |✓ | ||
+ | |‘X–I13401–P’ | ||
|- | |- | ||
|D2 | |D2 | ||
- | |2.65 μg I13401 | + | |2.65 μg I13401 |
- | | | + | |XbaI |
- | | | + | |PstI |
- | | | + | |2 (BioLabs) |
+ | |✓ | ||
+ | |‘X–I13401–P’ | ||
|} | |} | ||
Revision as of 17:31, 31 July 2010
Contents |
Lab work
Ordered DNA stocks
The DNA from Mr Gene has finally arrived, now we're ready to build some biobricks!
We were so excited; we immediately dissolved the DNA in water and performed a transformation with 100 ng of the DNA and plated on the LB agar containing the appropriate antibiotic.
- AlkB2 (Ampicillin)
- rubA3 (Ampicillin)
- rubA4 (Ampicillin)
- rubB (Kanamycin)
- ladA (Ampicillin)
- ADH (Ampicillin)
- ALDH (Kanamycin)
- bbc1 (Ampicillin)
- AlnA (Ampicillin)
- OprG (Ampicillin)
- PalkS1-2 (Ampicillin)
- PalkB (Ampicillin)
- P(CaiF) (Ampenicillin)
- AlkS (Kanamycin)
- PhPFD-α (Ampicillin)
- PhPFD-β (Ampicillin)
Characterization of Anderson RBS sequences
Yesterday's purified PCR product of I13401 and the Anderson RBS Biobricks (J61100, J61101, J61107, J61117 and J61127) were digested:
# | Sample | Enzyme 1 | Enzyme 2 | Buffer | BSA | Needed fragment |
C1 | 1.15 μg J61100 | SpeI | PstI | 2 (BioLabs) | ✓ | ‘S–J61100 pSB1A2–P’ |
C2 | 1.68 μg J61101 | SpeI | PstI | 2 (BioLabs) | ✓ | ‘S–J61101 pSB1A2–P’ |
C3 | 1.30 μg J61107 | SpeI | PstI | 2 (BioLabs) | ✓ | ‘S–J61107 pSB1A2–P’ |
C4 | 0.95 μg J61117 | SpeI | PstI | 2 (BioLabs) | ✓ | ‘S–J61117 pSB1A2–P’ |
C5 | 0.51 μg J61127 | SpeI | PstI | 2 (BioLabs) | ✓ | ‘S–J61127 pSB1A2–P’ |
D1 | 2.59 μg I13401 | XbaI | PstI | 2 (BioLabs) | ✓ | ‘X–I13401–P’ |
D2 | 2.65 μg I13401 | XbaI | PstI | 2 (BioLabs) | ✓ | ‘X–I13401–P’ |
The digestion products were purified using Roche's PCR Purifiation Kit and loaded onto a 1% agarose gel for comparison with the non-digested BioBricks:
Lane description:
# | Description | Expected Length (bp) | Remarks |
1 | SmartLadder marker (5 μL) | n/a | |
2 | Undigested J61100 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | Circular Plasmid | |
3 | Undigested J61101 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | Circular Plasmid | |
4 | ‘S – J61100 - pSB1A2 – P’ | 2116 | Visible |
5 | ‘S – J61101 - pSB1A2 – P’ | 2116 | Visible |
6 | Undigested J61107 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | Circular plasmid | |
7 | ‘S – J61107 - pSB1A2 – P’ | 2116 | Visible |
8 | Undigested J61117 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | Circular plasmid | |
9 | ‘S – J61117 - pSB1A2 – P’ | 2116 | Visible |
10 | Undigested J61127 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | Circular plasmid | |
11 | ‘S – J61127 - pSB1A2 – P’ | 2116 | Visible |
12 | Undigested I13401 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | Circular plasmid | |
13 | ‘X – I13401 – P’ | 883 | Visible |
14 | empty | empty | empty |
15 | BioRad EZ Load | n/a | Visible |
Followed by over night ligation:
# | BioBrick | Recipient plasmid | Fragment insert | Final volume |
1 | K398500A | 130 μg ‘S – J61100 - pSB1A2 – P’ | 154 μg ‘X-I13401-P’ | 26 μL |
2 | K398501A | 206 μg ‘S – J61101 - pSB1A2 – P’ | 247 μg ‘X-I13401-P’ | 25 μL |
3 | K398502A | 196 μg ‘S – J61107 - pSB1A2 – P’ | 247 μg ‘X-I13401-P’ | 25 μL |
4 | K398503A | 201 μg ‘S – J61117 - pSB1A2 – P’ | 247 μg ‘X-I13401-P’ | 25 μL |
5 | K398504A | 202 μg ‘S – J61127 - pSB1A2 – P’ | 247 μg ‘X-I13401-P’ | 25.5 μL |
6 | Ligase Control (J61117 - pSB1A2) | 123 μg ‘S – J61117 - pSB1A2 – P’ | None | 15 μL |
To all samples one-tenth of the total volume ligase buffer was added.
Emulsifier
Pieter is testing different condition for the emulsifying Assay. To determine the emulsifying activity we set up a calibration curve with SDS. He prepared the following samples:
# | Hexane (mL) | Tris Buffer pH 8 (mL) | 10% SDS (mL) |
B | 1 | 1.1 | 0 |
100 | 1 | 1 | 0.1 |
50 | 1 | 1.05 | 0.05 |
25 | 1 | 1.075 | 0.025 |
10 | 1 | 1.09 | 0.01 |
5 | 1 | 1.095 | 0.005 |
Kampioenen!!!!
Today the Dutch team will play the semi-final of the World Cup! Hear us cheer! Stop sound